214 related articles for article (PubMed ID: 9588912)
1. Spatial reproducibility of the ring and tandem high-dose rate cervix applicator.
Bahena JH; Martinez A; Yan D; Mele E; Edmunson G; Brown D; Hardy M; Brabbins D; Gustafson G
Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):13-9. PubMed ID: 9588912
[TBL] [Abstract][Full Text] [Related]
2. Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions.
Wulf J; Popp K; Oppitz U; Baier K; Flentje M
Strahlenther Onkol; 2004 Apr; 180(4):216-24. PubMed ID: 15057432
[TBL] [Abstract][Full Text] [Related]
3. Stability of Intracavitary Applicator Placement for HDR Brachytherapy of Cervix Cancer.
Balsdon A; Timotin E; Hunter R; Diamond K
J Med Imaging Radiat Sci; 2019 Sep; 50(3):441-448. PubMed ID: 31311722
[TBL] [Abstract][Full Text] [Related]
4. The variability of applicator position among high dose rate intracavitary brachytherapy applications in cervical cancer patients treated with ring & tandem applicators.
Ebruli C; Demiral AN; Cetingöz R; Eyiler F; Kinay M
Tumori; 2007; 93(5):432-8. PubMed ID: 18038874
[TBL] [Abstract][Full Text] [Related]
5. Problems and uncertainties with multiple point A's during multiple high-dose-rate intracavitary brachytherapy in carcinoma of the cervix.
Datta NR; Basu R; Das KJ; Rajasekar D; Pandey CM; Singh U; Ayyagari S
Clin Oncol (R Coll Radiol); 2004 Apr; 16(2):129-37. PubMed ID: 15074737
[TBL] [Abstract][Full Text] [Related]
6. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
7. Rapid involution and mobility of carcinoma of the cervix.
Lee CM; Shrieve DC; Gaffney DK
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):625-30. PubMed ID: 14751536
[TBL] [Abstract][Full Text] [Related]
8. A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.
Awunor O; Berger D; Kirisits C
Med Phys; 2015 Aug; 42(8):4472-83. PubMed ID: 26233177
[TBL] [Abstract][Full Text] [Related]
9. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU report 38.
Datta NR; Kumar S; Das KJ; Pandey CM; Halder S; Ayyagari S
Radiother Oncol; 2001 Jul; 60(1):15-24. PubMed ID: 11410299
[TBL] [Abstract][Full Text] [Related]
10. Problems in reporting doses and volumes during multiple high-dose-rate intracavitary brachytherapy for carcinoma cervix as per ICRU Report 38: a comparative study using flexible and rigid applicators.
Datta NR; Basu R; Das KJ; Rajasekar D; Pandey CM; Ayyagari S
Gynecol Oncol; 2003 Nov; 91(2):285-92. PubMed ID: 14599857
[TBL] [Abstract][Full Text] [Related]
11. Influence of different Fletcher-Suit applicator geometries on sagittal dose distribution.
Palvolgyi J
Phys Med; 2010 Jan; 26(1):49-54. PubMed ID: 19386528
[TBL] [Abstract][Full Text] [Related]
12. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
13. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
14. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
16. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix - A single-institute prospective study.
Suryadevara A; Kumar MV; Vasundhara E; Alluri KR; Ahamed S; Guduru S
Indian J Cancer; 2018; 55(3):230-232. PubMed ID: 30693884
[TBL] [Abstract][Full Text] [Related]
17. Changes in high-dose-rate tandem and ovoid applicator positions during treatment in an unfixed brachytherapy system.
Pham HT; Chen Y; Rouby E; Lustig RA; Wallner PE
Radiology; 1998 Feb; 206(2):525-31. PubMed ID: 9457208
[TBL] [Abstract][Full Text] [Related]
18. High dose rate (HDR) brachytherapy technique: for carcinoma of uterine cervix using Nucletron applicators.
Nair MT; Cheng MC; Barker A; Rouse BS
Med Dosim; 1995; 20(3):201-7. PubMed ID: 7576095
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
Tan LT; Coles CE; Hart C; Tait E
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
[TBL] [Abstract][Full Text] [Related]
20. Implementation of High Dose-rate Brachytherapy for Cervix Cancer in a Low-income Country.
Nurkic SR; Ocampo AI; Pinell Gadea MJ; Greenwalt J; Vicente MJ; Velasquez AL; Lopez Peralta LC; Herrera FS; Romero OC; Lopez Tenorio F; Zamora HL; Munguia LM; Yeung A
Ann Glob Health; 2018 Nov; 84(4):679-682. PubMed ID: 30779517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
